Markel Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-30,500
| Closed | -$22M | – | 135 |
|
|
2022
Q4 | $22M | Sell |
30,500
-49,800
| -62% | -$35.9M | 0.3% | 71 |
|
|
2022
Q3 | $55.3M | Hold |
80,300
| – | – | 0.82% | 34 |
|
|
2022
Q2 | $47.5M | Hold |
80,300
| – | – | 0.68% | 39 |
|
|
2022
Q1 | $56.1M | Buy |
80,300
+1,000
| +1% | +$698K | 0.67% | 39 |
|
|
2021
Q4 | $50.1M | Buy |
79,300
+5,000
| +7% | +$3.16M | 0.57% | 50 |
|
|
2021
Q3 | $45M | Buy |
74,300
+7,500
| +11% | +$4.54M | 0.57% | 50 |
|
|
2021
Q2 | $37.3M | Buy |
66,800
+21,300
| +47% | +$11.9M | 0.47% | 56 |
|
|
2021
Q1 | $21.5M | Buy |
+45,500
| New | +$21.5M | 0.3% | 74 |
|